Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01671865

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to identify and study changes in muscle in people with facioscapulohumeral muscular dystrophy using magnetic resonance imaging and spectroscopy.

Detailed description

This research study is being done to study changes in muscle imaging over time in people with facioscapulohumeral muscular dystrophy (FSHD). Whole-body magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) will be used to evaluate skeletal muscle in study participants. This research is being done to assess how changes in muscle imaging correspond to muscle strength and function. Qualified participants will be asked to complete 5 study visits over 21 months. Each visit will include muscle strength and function testing in addition to the MRI/MRS scan. The investigators plan to use MRI and MRS in developing outcome measures that can be used in future clinical trials for FSHD.

Conditions

Timeline

Start date
2012-03-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2012-08-24
Last updated
2025-07-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01671865. Inclusion in this directory is not an endorsement.